Telix Pharmaceuticals (Telix Pharmaceuticals) FCF Yield % : 0.25 (As of May. 13, 2024)

View and export this data going back to 2018. Start your Free Trial

What is Telix Pharmaceuticals FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Telix Pharmaceuticals's Trailing 12-Month Free Cash Flow is $8.8 Mil, and Market Cap is $3,444.2 Mil. Therefore, Telix Pharmaceuticals's FCF Yield % for today is 0.25%.

The historical rank and industry rank for Telix Pharmaceuticals's FCF Yield % or its related term are showing as below:

TLPPF' s FCF Yield % Range Over the Past 10 Years
Min: -15.79 Med: -3.46 Max: 0.43
Current: 0.25

During the past 9 years, the highest FCF Yield % of Telix Pharmaceuticals was 0.43%. The lowest was -15.79%. And the median was -3.46%.

TLPPF's FCF Yield % is ranked better than
87.01% of 1555 companies
in the Biotechnology industry
Industry Median: -14.28 vs TLPPF: 0.25

Telix Pharmaceuticals's FCF Margin % for the quarter that ended in Dec. 2023 was 1.02%.

Telix Pharmaceuticals FCF Yield % Historical Data

The historical data trend for Telix Pharmaceuticals's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Telix Pharmaceuticals FCF Yield % Chart

Telix Pharmaceuticals Annual Data

Trend

Sep99

Sep00

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

-6.34

0.15

-2.68

-3.52

0.39

Telix Pharmaceuticals Semi-Annual Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Yield %	Get a 7-Day Free Trial								-2.80	-10.83	-0.76	0.57	0.17

Competitive Comparison of Telix Pharmaceuticals's FCF Yield %

For the Biotechnology subindustry, Telix Pharmaceuticals's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Telix Pharmaceuticals's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Telix Pharmaceuticals's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Telix Pharmaceuticals's FCF Yield % falls into.

Telix Pharmaceuticals FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Telix Pharmaceuticals's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	8.762	/	2225.623125
	=	0.39%

Telix Pharmaceuticals's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	1.901	*	2	/	2225.623125
	=	0.17%

Telix Pharmaceuticals FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Telix Pharmaceuticals FCF Yield % Related Terms

Thank you for viewing the detailed overview of Telix Pharmaceuticals's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Telix Pharmaceuticals (Telix Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Telix Pharmaceuticals Ltd (OTCPK:TLPPF) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

TLX:Australia

Address

55 Flemington Road, Suite 401, North Melbourne, Melbourne, VIC, AUS, 3051

Website

https://www.telixpharma.com

Telix Pharmaceuticals Ltd is a clinical-stage biotechnology company engaged in developing and commercializing molecularly-targeted radiation therapy to address the unmet needs in the management of prostate, renal (kidney) and glioblastoma (brain) cancer. Geographically, it operates in Australia, the United States, Belgium, and Japan.